Zhang Y - Search Results

1

Integrative analysis based on ATAC-seq and RNA-seq reveals a novel oncogene PRPF3 in hepatocellular carcinoma.

Bai Y, Deng X, Chen D, Han S, Lin Z, Li Z, Tong W, Li J, Wang T, Liu X, Liu Z, Cui Z, Zhang Y. Bai Y, et al. Among authors: zhang y. Clin Epigenetics. 2024 Nov 5;16(1):154. doi: 10.1186/s13148-024-01769-w. Clin Epigenetics. 2024. PMID: 39501301 Free PMC article.

2

Upregulated microRNA-132 in T helper 17 cells activates hepatic stellate cells to promote hepatocellular carcinoma cell migration in vitro.

Feng R, Cui Z, Liu Z, Zhang Y. Feng R, et al. Among authors: zhang y. Scand J Immunol. 2021 May;93(5):e13007. doi: 10.1111/sji.13007. Epub 2020 Dec 19. Scand J Immunol. 2021. PMID: 33264420 Free article.

3

NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression.

Wang J, Zhang Y, Liu L, Cui Z, Shi R, Hou J, Liu Z, Yang L, Wang L, Li Y. Wang J, et al. Among authors: zhang y. BMC Cancer. 2020 Oct 6;20(1):966. doi: 10.1186/s12885-020-07474-0. BMC Cancer. 2020. PMID: 33023539 Free PMC article.

4

Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.

Li Y, Liu Z, Zhang Y. Li Y, et al. Among authors: zhang y. BMC Gastroenterol. 2021 Feb 22;21(1):79. doi: 10.1186/s12876-021-01643-6. BMC Gastroenterol. 2021. PMID: 33618667 Free PMC article.

5

DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.

Wu H, Zhang J, Bai Y, Zhang S, Zhang Z, Tong W, Han P, Fu B, Zhang Y, Shen Z. Wu H, et al. Among authors: zhang s, zhang j, zhang z, zhang y. Aging (Albany NY). 2021 Oct 4;13(19):23020-23035. doi: 10.18632/aging.203593. Epub 2021 Oct 4. Aging (Albany NY). 2021. PMID: 34609335 Free PMC article.

6

Enhancer RNA LINC00242-Induced Expression of PHF10 Drives a Better Prognosis in Pancreatic Adenocarcinoma.

Tong W, Zhu L, Bai Y, Yang L, Liu Z, Zhang Y. Tong W, et al. Among authors: zhang y. Front Oncol. 2022 Jan 20;11:795090. doi: 10.3389/fonc.2021.795090. eCollection 2021. Front Oncol. 2022. PMID: 35127503 Free PMC article.

7

Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencing.

Bai Y, Chen D, Cheng C, Li Z, Chi H, Zhang Y, Zhang X, Tang S, Zhao Q, Ang B, Zhang Y. Bai Y, et al. Among authors: zhang x, zhang y. Front Immunol. 2022 Jul 28;13:950536. doi: 10.3389/fimmu.2022.950536. eCollection 2022. Front Immunol. 2022. PMID: 35967424 Free PMC article.

8

Combined chemo/photothermal therapy based on mesoporous silica-Au core-shell nanoparticles for hepatocellular carcinoma treatment.

Wang J, Zhang Y, Liu L, Cui Z, Liu X, Wang L, Li Y, Li Q. Wang J, et al. Among authors: zhang y. Drug Dev Ind Pharm. 2019 Sep;45(9):1487-1495. doi: 10.1080/03639045.2019.1629688. Epub 2019 Jun 20. Drug Dev Ind Pharm. 2019. PMID: 31172835

9

Receptor Activator of Nuclear Factor (Nf)-kb Ligand Promotes T Helper 17 Cell Differentiation through Fas.

Cui Z, Feng R, Liu Z, Gong Y, Zhang Y. Cui Z, et al. Among authors: zhang y. Immunol Invest. 2022 Jul;51(5):1385-1397. doi: 10.1080/08820139.2021.1948050. Epub 2021 Jul 8. Immunol Invest. 2022. PMID: 34238108

10

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response.

Tong W, Wang G, Zhu L, Bai Y, Liu Z, Yang L, Wu H, Cui T, Zhang Y. Tong W, et al. Among authors: zhang y. Front Mol Biosci. 2022 Feb 21;8:793445. doi: 10.3389/fmolb.2021.793445. eCollection 2021. Front Mol Biosci. 2022. PMID: 35265666 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255,130 results

Search Page

Filters